Ranaldi R, Anderson K G, Carroll F I, Woolverton W L
Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS 39216, USA.
Psychopharmacology (Berl). 2000 Dec;153(1):103-10. doi: 10.1007/s002130000602.
The neuronal actions of methamphetamine (MA) include an increase in extracellular levels of monoamines, presumably via reverse transport involving the monoamine transporters. This action is thought to play an important role in the effects of MA. Therefore, in the present experiment, it was hypothesized that a monoamine uptake blocker would block behavioral effects of MA related to its abuse.
RTI 111, a newly synthesized 3-phenyltropane analog with high affinity for the dopamine, norepinephrine, and serotonin transporters, was evaluated alone and in combination with MA for its ability to block the reinforcing and discriminative stimulus effects of MA in rhesus monkeys.
RTI 111 (0.0003-0.03 mg/kg, i.v.) was made available to four rhesus monkeys for self-administration under a fixed-ratio 25 (FR 25) schedule of reinforcement. RTI 111 (0.01-0.1 mg/kg, i.m.) was also administered as a pretreatment (15 min prior) to four monkeys self-administering MA (0.0-0.3 mg/kg per injection, i.v.) on a progressive-ratio schedule of reinforcement. MA (0.01-1.0 mg/kg, i.m.), RTI 111 (0.001-0.1 mg/kg, i.m.), or the combination of MA and RTI 111 were administered to four monkeys trained to discriminate (+)-amphetamine (AMPH; 1.0 or 1.7 mg/kg, intragastric) from saline.
When RTI 111 was made available for self-administration under an FR 25 schedule it functioned as a positive reinforcer in all four monkeys tested. When RTI 111 was given as a pretreatment to monkeys self-administering MA under a progressive-ratio schedule, the MA dose-response function shifted to the left and down. When RTI 111 or MA were given to monkeys trained to discriminate AMPH from saline, full AMPH-like responding was observed for both drugs. Given in combination, RTI 111 shifted the MA dose-response function to the left.
These data suggest that RTI 111 is behaviorally similar to traditional psychomotor stimulants that act at the DA transporter and that it increases, rather than blocks, the behavioral potency of MA.
甲基苯丙胺(MA)的神经元作用包括细胞外单胺水平升高,推测是通过涉及单胺转运体的逆向转运实现的。这一作用被认为在MA的效应中起重要作用。因此,在本实验中,假设单胺摄取阻断剂会阻断与MA滥用相关的行为效应。
评估新合成的对多巴胺、去甲肾上腺素和5-羟色胺转运体具有高亲和力的3-苯基托烷类似物RTI 111单独及与MA联合使用时,阻断MA在恒河猴中强化和辨别刺激效应的能力。
将RTI 111(0.0003 - 0.03毫克/千克,静脉注射)提供给4只恒河猴,在固定比率25(FR 25)强化程序下进行自我给药。RTI 111(0.01 - 0.1毫克/千克,肌肉注射)也作为预处理(提前15分钟)给予4只在渐进比率强化程序下自我给药MA(每次注射0.0 - 0.3毫克/千克,静脉注射)的猴子。将MA(0.01 - 1.0毫克/千克,肌肉注射)、RTI 111(0.001 - 0.1毫克/千克,肌肉注射)或MA与RTI 111的组合给予4只经过训练以区分(+)-苯丙胺(AMPH;1.0或1.7毫克/千克,灌胃)和生理盐水的猴子。
当RTI 111在FR 25程序下可供自我给药时,它在所有4只受试猴子中起到了阳性强化物的作用。当RTI 111作为预处理给予在渐进比率程序下自我给药MA的猴子时,MA剂量 - 反应函数向左下方移动。当将RTI 111或MA给予经过训练以区分AMPH和生理盐水的猴子时,两种药物均观察到完全类似AMPH的反应。联合给药时,RTI 111使MA剂量 - 反应函数向左移动。
这些数据表明,RTI 111在行为上与作用于多巴胺转运体的传统精神运动兴奋剂相似,并且它增加而非阻断MA的行为效力。